3.785
price up icon2.30%   0.085
after-market After Hours: 3.79 0.005 +0.13%
loading
Cytek Biosciences Inc stock is traded at $3.785, with a volume of 505.27K. It is up +2.30% in the last 24 hours and down -9.88% over the past month. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$3.70
Open:
$3.76
24h Volume:
505.27K
Relative Volume:
0.62
Market Cap:
$476.52M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-42.06
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
+1.75%
1M Performance:
-9.88%
6M Performance:
-25.64%
1Y Performance:
-34.74%
1-Day Range:
Value
$3.715
$3.83
1-Week Range:
Value
$3.47
$3.83
52-Week Range:
Value
$3.27
$7.63

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name
Name
Cytek Biosciences Inc
Name
Phone
(877) 922-9835
Name
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Name
Employee
648
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
CTKB's Discussions on Twitter

Compare CTKB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
CTKB
Cytek Biosciences Inc
3.785 476.52M 193.01M -12.15M 454.00K -0.09
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-31-25 Downgrade Goldman Buy → Sell
Dec-14-23 Initiated Stephens Overweight
Jul-19-23 Initiated Raymond James Mkt Perform
Jan-06-22 Resumed Piper Sandler Overweight

Cytek Biosciences Inc Stock (CTKB) Latest News

pulisher
Apr 20, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Geode Capital Management LLC - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

JPMorgan Chase & Co. Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Apr 18, 2025
pulisher
Apr 16, 2025

Is Cytek Biosciences (NASDAQ:CTKB) Using Too Much Debt? - simplywall.st

Apr 16, 2025
pulisher
Apr 11, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Vanguard Group Inc. - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Decreases Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Apr 10, 2025
pulisher
Apr 10, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by American Century Companies Inc. - Defense World

Apr 10, 2025
pulisher
Apr 10, 2025

KLP Kapitalforvaltning AS Takes $131,000 Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Apr 10, 2025
pulisher
Apr 07, 2025

Cytek Biosciences stock hits 52-week low at $3.51 amid market challenges - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Trading (CTKB) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 07, 2025
pulisher
Apr 07, 2025

Prudential Financial Inc. Has $1.13 Million Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

Raymond James Financial Inc. Buys New Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Apr 06, 2025
pulisher
Apr 04, 2025

Thrivent Financial for Lutherans Sells 3,001 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

Cell Analyzer | Cytek Biosciences Inc. | Products - Photonics Spectra

Apr 02, 2025
pulisher
Mar 31, 2025

106,597 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Purchased by Teacher Retirement System of Texas - Defense World

Mar 31, 2025
pulisher
Mar 29, 2025

Proficio Capital Partners LLC Invests $71,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Cytek Biosciences stock hits 52-week low at $3.99 amid market shifts - Investing.com India

Mar 28, 2025
pulisher
Mar 27, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by PNC Financial Services Group Inc. - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek Muse Micro System - SelectScience

Mar 27, 2025
pulisher
Mar 24, 2025

Charles Schwab Investment Management Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.2% – What’s Next? - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Stephens Reiterates “Overweight” Rating for Cytek Biosciences (NASDAQ:CTKB) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Cytek Biosciences stock hits 52-week low at $4.05 - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Cytek Biosciences stock hits 52-week low at $4.05 By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 19, 2025

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - The Manila Times

Mar 19, 2025
pulisher
Mar 18, 2025

Cytek Biosciences Launches Next-Generation Muse Micro Cell Analyzer to Transform Flow Cytometry Accessibility - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Revolutionary Budget-Friendly Cell Analyzer Transforms Biotech Research Accessibility - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

Bank of New York Mellon Corp Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 18, 2025
pulisher
Mar 14, 2025

Proficio Capital Partners LLC Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 10, 2025

Cytek Biosciences (CTKB) to Release Earnings on Wednesday - The AM Reporter

Mar 10, 2025
pulisher
Mar 08, 2025

Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey

Mar 08, 2025
pulisher
Mar 06, 2025

12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey

Mar 06, 2025
pulisher
Mar 05, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Cytek Biosciences (CTKB) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Principal Financial Group Inc. - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Cytek Biosciences (NASDAQ:CTKB) Price Target Cut to $8.00 by Analysts at Piper Sandler - Defense World

Mar 05, 2025
pulisher
Mar 03, 2025

Cytek Biosciences Reports Mixed Earnings Amid Growth and Challenges - TipRanks

Mar 03, 2025
pulisher
Mar 02, 2025

Cytek Biosciences (NASDAQ:CTKB) Hits New 1-Year Low – Here’s Why - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges - Investing.com Australia

Mar 01, 2025
pulisher
Mar 01, 2025

Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation? - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Cytek Biosciences, Inc. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

Cytek Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 28, 2025

Cytek Biosciences Inc Stock (CTKB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Cap:     |  Volume (24h):